Literature DB >> 32935295

Diversity in cancer invasion phenotypes indicates specific stroma regulated programs.

Yasir Suhail1,2,3, Visar Ajeti1,3, Ruchi Goyal1, Khadija Wali1,4, Atta Seck1,5, Ashkan Novin1,2, Alex Jackson1.   

Abstract

Tumor dissemination into the surrounding stroma is the initial step in a metastatic cascade. Invasion into stroma is a non-autonomous process for cancer, and its progression depends upon the stage of cancer, as well as the cells residing in the stroma. However, a systems framework to understand how stromal fibroblasts resist, collude, or aid cancer invasion has been lacking, limiting our understanding of the role of stromal biology in cancer metastasis. We and others have shown that gene perturbation in stromal fibroblasts can modulate cancer invasion into the stroma, highlighting the active role stroma plays in regulating its own invasion. However, cancer invasion into stroma is a complex higher-order process and consists of various sub-phenotypes that together can result in an invasion. Stromal invasion exhibits a diversity of modalities in vivo. It is not well understood if these diverse modalities are correlated, or they emanate from distinct mechanisms and if stromal biology could regulate these characteristics. These characteristics include the extent of invasion, formation, and persistence of invasive forks by cancer as opposed to a collective frontal invasion, the persistence of invading velocity by leader cells at the tip of invasive forks, etc. We posit that quantifying distinct aspects of collective invasion can provide useful suggestions about the plausible mechanisms regulating these processes, including whether the process is regulated by mechanics or by intercellular communication between stromal cells and cancer. Here, we have identified the sub-characteristics of invasion, which might be indicative of broader mechanisms regulating these processes, developed methods to quantify these metrics, and demonstrated that perturbation of stromal genes can modulate distinct aspects of collective invasion. Our results highlight that the genetic state of stromal fibroblasts can regulate complex phenomena involved in cancer dissemination and suggest that collective cancer invasion into stroma is an outcome of the complex interplay between cancer and stromal fibroblasts.

Entities:  

Keywords:  Cancer-stroma interaction; Collective invasion; Stromal invasion

Mesh:

Year:  2020        PMID: 32935295     DOI: 10.1007/s13577-020-00427-6

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  26 in total

1.  Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activation.

Authors:  Andrea Clocchiatti; Soumitra Ghosh; Maria-Giuseppina Procopio; Luigi Mazzeo; Pino Bordignon; Paola Ostano; Sandro Goruppi; Giulia Bottoni; Atul Katarkar; Mitchell Levesque; Peter Kölblinger; Reinhard Dummer; Victor Neel; Berna C Özdemir; G Paolo Dotto
Journal:  J Clin Invest       Date:  2018-11-05       Impact factor: 14.808

Review 2.  Systems Biology of Cancer Metastasis.

Authors:  Yasir Suhail; Margo P Cain; Kiran Vanaja; Paul A Kurywchak; Andre Levchenko; Raghu Kalluri
Journal:  Cell Syst       Date:  2019-08-28       Impact factor: 10.304

3.  Collective invasion in breast cancer requires a conserved basal epithelial program.

Authors:  Kevin J Cheung; Edward Gabrielson; Zena Werb; Andrew J Ewald
Journal:  Cell       Date:  2013-12-12       Impact factor: 41.582

Review 4.  Emerging Biological Principles of Metastasis.

Authors:  Arthur W Lambert; Diwakar R Pattabiraman; Robert A Weinberg
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

5.  Distinguishing mechanisms underlying EMT tristability.

Authors:  Dongya Jia; Mohit Kumar Jolly; Satyendra C Tripathi; Petra Den Hollander; Bin Huang; Mingyang Lu; Muge Celiktas; Esmeralda Ramirez-Peña; Eshel Ben-Jacob; José N Onuchic; Samir M Hanash; Sendurai A Mani; Herbert Levine
Journal:  Cancer Converg       Date:  2017-11-01

6.  Stability of the hybrid epithelial/mesenchymal phenotype.

Authors:  Mohit Kumar Jolly; Satyendra C Tripathi; Dongya Jia; Steven M Mooney; Muge Celiktas; Samir M Hanash; Sendurai A Mani; Kenneth J Pienta; Eshel Ben-Jacob; Herbert Levine
Journal:  Oncotarget       Date:  2016-05-10

7.  Cancer-associated fibroblasts enhance tumor 18F-FDG uptake and contribute to the intratumor heterogeneity of PET-CT.

Authors:  Chengfang Shangguan; Guifang Gan; Jieying Zhang; Jinliang Wu; Ying Miao; Miao Zhang; Biao Li; Jun Mi
Journal:  Theranostics       Date:  2018-02-02       Impact factor: 11.556

8.  E-cadherin is required for metastasis in multiple models of breast cancer.

Authors:  Veena Padmanaban; Ilona Krol; Yasir Suhail; Barbara M Szczerba; Nicola Aceto; Joel S Bader; Andrew J Ewald
Journal:  Nature       Date:  2019-09-04       Impact factor: 49.962

9.  Twist1-induced dissemination preserves epithelial identity and requires E-cadherin.

Authors:  Eliah R Shamir; Elisa Pappalardo; Danielle M Jorgens; Kester Coutinho; Wen-Ting Tsai; Khaled Aziz; Manfred Auer; Phuoc T Tran; Joel S Bader; Andrew J Ewald
Journal:  J Cell Biol       Date:  2014-03-03       Impact factor: 10.539

10.  Distinct EMT programs control normal mammary stem cells and tumour-initiating cells.

Authors:  Xin Ye; Wai Leong Tam; Tsukasa Shibue; Yasemin Kaygusuz; Ferenc Reinhardt; Elinor Ng Eaton; Robert A Weinberg
Journal:  Nature       Date:  2015-09-02       Impact factor: 49.962

View more
  2 in total

1.  Metastatic Transition of Pancreatic Ductal Cell Adenocarcinoma Is Accompanied by the Emergence of Pro-Invasive Cancer-Associated Fibroblasts.

Authors:  Shaofei Liu; Yasir Suhail; Ashkan Novin; Lorrie Perpetua
Journal:  Cancers (Basel)       Date:  2022-04-28       Impact factor: 6.575

2.  Paracrine HB-EGF signaling reduce enhanced contractile and energetic state of activated decidual fibroblasts by rebalancing SRF-MRTF-TCF transcriptional axis.

Authors:  Junaid Afzal; Wenqiang Du; Ashkan Novin; Yamin Liu; Khadija Wali; Anarghya Murthy; Ashley Garen; Gunter Wagner
Journal:  Front Cell Dev Biol       Date:  2022-09-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.